Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase NA 3Phase 4 1Phase 3 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Polycystic Ovary Syndrome 7Breast Neoplasms 3Hyperandrogenism 2Vaginitis 1Atrophic Vaginitis 1

Interventions

Exercise 112Surveys and Questionnaires 56Early Intervention, Educational 49Standard of Care 46Methods 46Magnetic Resonance Spectroscopy 45Blood Specimen Collection 44Acupuncture Therapy 44Educational Status 43Radiotherapy 36Mammography 36Control Groups 31Therapeutics 29Counseling 29Psychiatric Rehabilitation 27Cyclophosphamide 27Sentinel Lymph Node Biopsy 25Biopsy 24Yoga 20Mastectomy, Segmental 20Resistance Training 19Palliative Care 18Neoadjuvant Therapy 18High-Energy Shock Waves 18Doxorubicin 18Cognitive Behavioral Therapy 18Magnetic Resonance Imaging 17Practice Guidelines as Topic 16Paclitaxel 16Trastuzumab 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Breast Neoplasms × Estradiol × Clear all
NCT00984399 2025-12-09

Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen

Memorial Sloan Kettering Cancer Center

Phase NA Completed
31 enrolled 12 charts
Breast

Breast Neoplasms, Vaginitis, Atrophic Vaginitis

NCT01385280 2018-10-17

Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer

University of Arizona

Phase NA Completed
13 enrolled 6 charts
Breast

Breast Neoplasms

NCT02528383 2017-09-18

Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors

UConn Health

Phase NA Completed
3 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡